Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.49 |
| ▸ | CA1 | P00915 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.46 |
| ▸ | TERT | O14746 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 1/20 | 0.44 |
| ▸ | PYGL | P06737 | 1/20 | 0.42 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.41 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18285162 | 1.00 | CA2 (0.49) | CA2CA1KDM4EALDH1A1LMNA | |
| SCHEMBL6809240 | 1.00 | CA2 (0.49) | CA2CA1KDM4EALDH1A1LMNA | |
| SCHEMBL27536297 | 1.00 | CA2 (0.49) | CA2CA1KDM4EALDH1A1LMNA | |
| SCHEMBL17403869 | 0.88 | KDM4E (0.62) | CA2CA1KDM4EALDH1A1LMNA | |
| SCHEMBL17404128 | 0.88 | KDM4E (0.62) | CA2CA1KDM4EALDH1A1LMNA | |
| SCHEMBL20211507 | 0.87 | KDM4E (0.40) | CA2CA1KDM4EALDH1A1LMNA | |
| SCHEMBL18285159 | 0.87 | KDM4E (0.40) | CA2CA1KDM4EALDH1A1LMNA | |
| SCHEMBL18285008 | 0.86 | KDM4E (0.39) | CA2CA1KDM4EALDH1A1LMNA | |
| SCHEMBL29885579 | 0.85 | MMP2 (0.50) | CA2CA1KDM4EALDH1A1LMNA | |
| SCHEMBL18332893 | 0.83 | KDM4E (0.55) | CA2CA1KDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040132707-A1 | Catecholate beta-lactam conjugates, method for producing the same and the use thereof | GRUENENTHAL GMBH (DE) | 2004-07-08 | — | — | US | disclosed |
| EP-1370296-A2 | CATECHOLATE BETA-LACTAM CONJUGATES, METHOD FOR PRODUCING THE SAME AND THE USE THEREOF | Grünenthal GmbH (DE) | 2003-12-17 | — | — | EP | disclosed |
| CN-1106380-C | New synthetic catechol derivatives, method for production and use thereof | GRILENTHAL GMBH (DE) | 2003-04-23 | — | — | CN | disclosed |
| WO-2002070545-A2 | SIDEROPHORE ANALOGUES AS TETRA- OR HEXADENTATE IRON CHELATORS ON THE BASIS OF AMINO ACIDS OR PEPTIDES, METHOD FOR PRODUCING THEM AND THE USE THEREOF | Grünenthal GmbH (DE) | 2002-09-12 | — | — | WO | disclosed |
| WO-2002070017-A1 | SIDEROPHORE ANTIBIOTIC CONJUGATES WITH TETRA- OR HEXADENTATE IRON CHELATORS ON THE BASIS OF AMINO ACIDS OR PEPTIDES, METHOD FOR PRODUCING THEM AND THE USE THEREOF | Grünenthal GmbH (EP) | 2002-09-12 | — | — | WO | disclosed |
| WO-2002070016-A2 | CATECHOLATE BETA-LACTAM CONJUGATES, METHOD FOR PRODUCING THE SAME AND THE USE THEREOF | Grünenthal GmbH (DE) | 2002-09-12 | — | — | WO | disclosed |
| US-6380181-B1 | AMINO ACID RESIDUES IN THE 3-AND/OR 4-POSITION FUNCTION AS SIDEROPHORES AND/OR AS BIOLOGICAL CHELATING AGENTS FOR IRON IN GRAM-NEGATIVE BACTERIA | GRUENENTHAL GMBH (DE) | 2002-04-30 | — | — | US | disclosed |
| EP-0907633-B1 | NEW SYNTHETIC CATECHOL DERIVATIVES, METHOD FOR PRODUCTION AND USE THEREOF | GRUENENTHAL GMBH (DE) | 2001-08-22 | — | — | EP | disclosed |
| EP-0863139-B1 | Benzoxazindione derivatives, process for their preparation and their use | GRUENENTHAL GMBH (DE) | 2001-03-28 | — | — | EP | disclosed |
| US-6013647-A | BACTERICIDES | GRUENENTHAL GMBH (DE) | 2000-01-11 | — | — | US | disclosed |
| CN-1222905-A | New synthetic catechol derivatives, method for production and use thereof | GRILENTHAL GMBH (DE) | 1999-07-14 | — | — | CN | disclosed |
| EP-0907633-A1 | NEW SYNTHETIC CATECHOL DERIVATIVES, METHOD FOR PRODUCTION AND USE THEREOF | Grünenthal GmbH (DE) | 1999-04-14 | — | — | EP | disclosed |
| EP-0863139-A1 | Benzoxazindione derivatives, process for their preparation and their use | Grünenthal GmbH (DE) | 1998-09-09 | — | — | EP | disclosed |
| WO-1997049670-A1 | NEW SYNTHETIC CATECHOL DERIVATIVES, METHOD FOR PRODUCTION AND USE THEREOF | Grünenthal GmbH (DE) | 1997-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132707-A1 | Catecholate beta-lactam conjugates, method for producing the same and the use thereof | COMT, CAT, SLC7A11 | CA2 774/4885CA1 570/4885KDM4E 3812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.